Real-World Safety and Effectiveness of Denosumab in Patients with Osteoporosis: A Prospective, Observational Study in South Korea

Yumie RHEE; Dong-Gune CHANG; Jeonghoon HA; Sooa KIM; Yusun LEE; Euna JO; Jung-Min KOH.
Endocrinology and Metabolism ; : 497-505, 2022.
Artículo en Inglés | WPRIM | ID: wpr-937434

Documentos relacionados

  1. Real-World Safety and Effectiveness of Denosumab in Patients with Osteoporosis: A Prospective, Observational Study in South Korea.
  2. [Non-pharmacological treatment of osteoporosis: myth or reality?].
  3. [Diagnosing osteoporosis: what is new in the 2014 DVO guideline?].
  4. [Pharmacotherapy of osteoporosis: evidence-based clinical practice].
  5. [Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project].
  6. [Diabetes and osteoporosis: pathophysiological interactions and clinical importance for geriatric patients].
  7. Perfil de segurança dos soros heterólogos produzidos pelo Instituto Butantan, São Paulo-SP, no período de 2012 a 2015
  8. [The use of parenteral clodronate in elderly women with postmenopausal osteoporosis: compliance, effects on bone mineral density and on bone turnover].